Development and internal validation of a clinical prediction model for 90-day mortality after lung resection: the RESECT-90 score.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
22 11 2021
Historique:
received: 27 01 2021
revised: 19 05 2021
accepted: 24 06 2021
pubmed: 30 7 2021
medline: 8 3 2022
entrez: 29 7 2021
Statut: ppublish

Résumé

The ability to accurately estimate the risk of peri-operative mortality after lung resection is important. There are concerns about the performance and validity of existing models developed for this purpose, especially when predicting mortality within 90 days of surgery. The aim of this study was therefore to develop a clinical prediction model for mortality within 90 days of undergoing lung resection. A retrospective database of patients undergoing lung resection in two UK centres between 2012 and 2018 was used to develop a multivariable logistic risk prediction model, with bootstrap sampling used for internal validation. Apparent and adjusted measures of discrimination (area under receiving operator characteristic curve) and calibration (calibration-in-the-large and calibration slope) were assessed as measures of model performance. Data were available for 6600 lung resections for model development. Predictors included in the final model were age, sex, performance status, percentage predicted diffusion capacity of the lung for carbon monoxide, anaemia, serum creatinine, pre-operative arrhythmia, right-sided resection, number of resected bronchopulmonary segments, open approach and malignant diagnosis. Good model performance was demonstrated, with adjusted area under receiving operator characteristic curve, calibration-in-the-large and calibration slope values (95% confidence intervals) of 0.741 (0.700, 0.782), 0.006 (-0.143, 0.156) and 0.870 (0.679, 1.060), respectively. The RESECT-90 model demonstrates good statistical performance for the prediction of 90-day mortality after lung resection. A project to facilitate large-scale external validation of the model to ensure that the model retains accuracy and is transferable to other centres in different geographical locations is currently underway.

Identifiants

pubmed: 34324664
pii: 6330759
doi: 10.1093/icvts/ivab200
pmc: PMC8632783
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

921-927

Subventions

Organisme : North West Thoracic Surgery Collaborative

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Marcus Taylor (M)

Department of Cardiothoracic Surgery, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.

Glen P Martin (GP)

Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester Academic Heath Science Centre, University of Manchester, Manchester, UK.

Udo Abah (U)

Department of Cardiothoracic Surgery, Liverpool Heart & Chest Hospital, Liverpool, UK.

Matthew Sperrin (M)

Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester Academic Heath Science Centre, University of Manchester, Manchester, UK.

Matthew Smith (M)

Department of Cardiothoracic Surgery, Liverpool Heart & Chest Hospital, Liverpool, UK.

Dilraj Bhullar (D)

Department of Cardiothoracic Surgery, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.

Michael Shackcloth (M)

Department of Cardiothoracic Surgery, Liverpool Heart & Chest Hospital, Liverpool, UK.

Steve Woolley (S)

Department of Cardiothoracic Surgery, Liverpool Heart & Chest Hospital, Liverpool, UK.

Doug West (D)

Division of Surgery, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Rajesh Shah (R)

Department of Cardiothoracic Surgery, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.

Stuart W Grant (SW)

Division of Cardiovascular Sciences, University of Manchester, ERC, Manchester University Hospital NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH